Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Allarity Therapeutics Inc. Common Stock
ALLR | US
1.69
USD-0.03
-1.74%
ALLR | US
About Allarity Therapeutics Inc. Common Stock
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
02/06/2026
Close
1.69
Open
1.68
High
1.74
Low
1.63
Allarity Therapeutics Inc. a clinical-stage biopharmaceutical company engages in developing oncology therapeutics using drug-specific companion diagnostics generated by its drug response predictor technology. Its drug candidates include Stenoparib a poly-ADP-ribose polymerase inhibitor that is in Phase 2 clinical trials for ovarian cancer; Dovitinib a pan- tyrosine kinase inhibitor for the treatment of renal cell carcinoma; IXEMPRA (ixabepilone) a selective microtubule inhibitor for the treatment of metastatic breast cancer; LiPlaCis a liposomal formulation of cisplatin which is in Phase 2 clinical trials for metastatic breast cancer; and 2X-111 a liposomal formulation of doxorubicin that is in Phase 2 clinical trials for metastatic breast cancer and glioblastoma multiforme. The company was incorporated in 2004 and is headquartered in Boston Massachusetts.
View LessALLR | US
Risk
96.5
Sharpe
0.91
Luna's Score
58/100
Recommendation
Hold
Luna says (ALLR | US)
What's Working
Positive Momentum
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
What's not Working
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
80.5%1 month
96.5%3 months
86.0%6 months
82.7%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
0.12
Debt to equity
0.07
Debt to assets
0.04
Ent. to EBITDA
-0.08
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-16.89M
MarketCap
2.39M
MarketCap(USD)
2.39M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-121.82
Short ratio
0.15
Short perc.
10.03
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.48
Range1M
0.60
Range3M
0.89
Volumes: Market Activity
Rel. volume
0.56
Price X volume
274.90K
